We are live on
!
Find out more
SCM
Suvretta Capital Management Portfolio holdings
AUM
$3.92B
1-Year Est. Return
86.67%
This Fund
S&P 500
This Quarter
Est. Return
+29.15%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$4.65B
AUM Growth
+$951M
(+26%)
Cap. Flow
+$238M
Cap. Flow
% of AUM
5.12%
Top 10 Holdings %
Top 10 Hldgs %
42.35%
Holding
109
New
44
Increased
20
Reduced
16
Closed
29
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$233M |
| 2 |
Otis Worldwide
OTIS
|
+$135M |
| 3 |
Royalty Pharma
RPRX
|
+$107M |
| 4 |
Baxter International
BAX
|
+$105M |
| 5 |
Five Below
FIVE
|
+$104M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$226M |
| 2 |
Boston Scientific
BSX
|
+$147M |
| 3 |
Johnson & Johnson
JNJ
|
+$121M |
| 4 |
Fidelity National Information Services
FIS
|
+$99.8M |
| 5 |
Amazon
AMZN
|
+$68.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.01% |
| 2 | Technology | 20.81% |
| 3 | Industrials | 20.34% |
| 4 | Consumer Discretionary | 17.45% |
| 5 | Communication Services | 11.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TPTX
76
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $1.63M | 0.04% |
25,231
-7,069
| -22% | -$408K |
|
|
OPENW
77
DELISTED
Opendoor Technologies Inc Warrants expiring 12/18/2025
OPENW
| $1.47M | 0.03% |
+404,666
| New | +$1.5M |
|
78
Spyre Therapeutics
SYRE
$9.25B
| $1.09M | 0.02% |
+4,717
| New | +$898K |
|
79
Q32 Bio
QTTB
$464M
| $1.07M | 0.02% |
3,931
+109
| +3% | +$29.1K |
|
|
CHMA
80
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $1.04M | 0.02% |
+193,805
| New | +$1.07M |
|
|
APLS
81
DELISTED
Apellis Pharmaceuticals
APLS
| – | – |
-21,600
| Closed | -$579K |
|
82
argenx
ARGX
$54.1B
| – | – |
-3,320
| Closed | -$437K |
|
83
Arvinas
ARVN
$572M
| – | – |
-5,650
| Closed | -$228K |
|
84
Alibaba
BABA
$308B
| – | – |
-331,040
| Closed | -$64.4M |
|
85
Biogen
BIIB
$30.7B
| – | – |
-153,670
| Closed | -$48.6M |
|
86
Chipotle Mexican Grill
CMG
$41.5B
| – | – |
-3,252,500
| Closed | -$42.6M |
|
|
87
Salesforce
CRM
$158B
| – | – |
-1,572,771
| Closed | -$226M |
|
88
CVS Health
CVS
$122B
| – | – |
-1,081,000
| Closed | -$64.1M |
|
89
Deere & Co
DE
$168B
| – | – |
-480,276
| Closed | -$66.4M |
|
90
DXC Technology
DXC
$1.73B
| – | – |
-652,240
| Closed | -$8.51M |
|
91
General Dynamics
GD
$106B
| – | – |
-170,000
| Closed | -$22.5M |
|
92
CALL
Heron Therapeutics
HRTX
$92.9M
| – | – |
-53,000
| Closed | -$622K |
|
|
93
Heron Therapeutics
HRTX
$92.9M
| – | – |
-40,500
| Closed | -$475K |
|
94
Iovance Biotherapeutics
IOVA
$2.87B
| – | – |
-30,000
| Closed | -$898K |
|
95
JD.com
JD
$44.5B
| – | – |
-752,350
| Closed | -$30.5M |
|
|
96
Johnson & Johnson
JNJ
$625B
| – | – |
-925,930
| Closed | -$121M |
|
97
Lyft
LYFT
$6.63B
| – | – |
-368,750
| Closed | -$9.9M |
|
98
Monster Beverage
MNST
$88.5B
| – | – |
-2,234,000
| Closed | -$62.8M |
|
99
Puma Biotechnology
PBYI
$454M
| – | – |
-71,500
| Closed | -$603K |
|
100
Regenxbio
RGNX
$708M
| – | – |
-20,820
| Closed | -$674K |
|
Similar funds
MIM
BCP
AS
MSI
FLSM
LWCA
TFM
USCWA
Suvretta Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Suvretta Capital Management held 109 positions worth $4.65B, up 26% from $3.7B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Suvretta Capital Management deployed $238M of net new capital in Q2 2020, opening 44 new positions and adding to 20 existing holdings. Its largest new stake was Meta Platforms (Facebook): 1,114,740 shares worth $253M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 26% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Boston Scientific, an estimated $147M trimmed.
- Suvretta Capital Management's largest Q2 2020 buy was Meta Platforms (Facebook): 1,114,740 shares worth $253M.
- Suvretta Capital Management added most to Uber in Q2 2020, an estimated $82.8M increase.
- Suvretta Capital Management's biggest Q2 2020 reduction was Boston Scientific, cutting an estimated $147M.
- Suvretta Capital Management fully exited Salesforce in Q2 2020, selling an estimated $226M.
- Suvretta Capital Management's ten largest holdings make up 42% of its $4.65B portfolio in Q2 2020.
- Suvretta Capital Management opened 44 new positions and closed 29 in Q2 2020.
- Suvretta Capital Management's portfolio value rose 26% quarter-over-quarter to $4.65B.
Based on Suvretta Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.